Skip Navigation

Pregnancy & Contraception in Microbide Development

Skip sharing on social media links
This news is archived NICHD Archive
Note:This event has already taken place and the page is no longer being updated.

March 9-10, 2009


Demographic and Behavioral Sciences (DBS) Branch, Center for Population Research (CPR), NICHD; Contraception and Reproductive Health Branch, CPR, NICHD; Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, NICHD; Office of AIDS Research, Office of the Director (OD), NIH; Office of Research on Women's Health, OD, NIH; National Institute of Allergy and Infectious Disease, NIH


Bethesda, Maryland


One of the major complications in performing large-scale prevention trials in women, including those for microbicide development, is the loss of time on study of a drug due to pregnancy. This workshop tasked six study groups to address the issues of contraception and pregnancy on the outcome, or potential outcomes, in clinical trials. This meeting represented the first comparison of pregnancy rates across several large studies. The knowledge expressed at this meeting and summarized in the proceedings document may assist others in planning HIV prevention-related clinical studies in women.


Dr. Patricia S. Reichelderfer, NICHD
Tel: (301) 435-6991

Last Reviewed: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology